John McKearn
Biotechnology Consultant at RiverVest Venture Partners
United States
John McKearn, Biotechnology Consultant at RiverVest Venture Partners is an active investor based in United States. This profile covers what John McKearn backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPESyndicateInvestor
- Stages
- Early Stage VenturePre SeedSeed
- Invests in
- Biotech & PharmaHealthcare & BiotechMedTech & Medical DevicesClimate & Energy
- Location
- United States
- Typical check
- $250K
- Past investments
- 40
Notable investments
Genoa Pharmaceuticals
Spruce Biosciences
OncoResponse
Lutonix
Standard Bariatrics
Smart WiresAmplyx Pharmaceuticals
Arch Oncology
Venture Med GroupAuxeris Therapeutics
KereosIDM PharmaHow to reach John McKearn
Angels and operators like John McKearn reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with John McKearn
Frequently Asked Questions
What does John McKearn invest in?
John McKearn invests in Biotech & Pharma, Healthcare & Biotech, MedTech & Medical Devices and Climate & Energy, typically at Early Stage Venture, Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does John McKearn invest at?
John McKearn typically invests at Early Stage Venture, Pre Seed and Seed. Lead with traction that fits the stage when you reach out.
What is John McKearn's typical check size?
John McKearn typically writes checks around $250K. Use it as a signal for whether your raise fits their stage.
How do I contact John McKearn?
Unlock John McKearn's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.